Research Protocol - Effect of anti-staphylococcal antibiotic prophylaxis upon isolation and colonisation with Staphylococcus aureus, Pseudomonas aeruginosa and their resistant variants in cystic fibrosis

QR Code

Research Protocol - Effect of anti-staphylococcal antibiotic prophylaxis upon isolation and colonisation with Staphylococcus aureus, Pseudomonas aeruginosa and their resistant variants in cystic fibrosis

Bibliographic Details
Main Authors:	Hurley, Matthew, Smyth, Alan R., Fogarty, Andrew W., McKeever, Tricia M., Rosenfeld, Margaret, Goss, Christopher
Format:	Other
Published:	University of Nottingham 2016
Online Access:	https://eprints.nottingham.ac.uk/37205/

Similar Items

Early respiratory bacterial detection and anti-staphylococcal antibiotic prophylaxis in young children with cystic fibrosis
by: Hurley, Matthew, et al.
Published: (2017)

Prophylactic anti-staphylococcal antibiotics for cystic fibrosis
by: Smyth, Alan R., et al.
Published: (2014)

Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2012)

Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis
by: Langton Hewer, Simon C., et al.
Published: (2014)

Airway infection and Pseudomonas aeruginosa in bronchiectasis (cystic fibrosis and non-cystic fibrosis bronchiectasis)
by: Webb, Karmel
Published: (2022)

The role of Chlorhexidine in Staphylococcal aureus prophylaxis
by: Concoran, E., et al.
Published: (2005)

Pseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosis
by: Barr, Helen L., et al.
Published: (2015)

Mitigating the harm caused by Pseudomonas aeruginosa in Cystic Fibrosis
by: Palser, Sally C.
Published: (2024)

Delayed publications of clinical trials in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2011)

Aspirated bile: a major host trigger modulating respiratory pathogen colonisation in cystic fibrosis patients
by: Reen, F., et al.
Published: (2014)

Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: a longitudinal study
by: Barr, Helen L., et al.
Published: (2017)

Cystic fibrosis microbiology: advances in antimicrobial therapy
by: Waters, Valerie, et al.
Published: (2015)

Exhaled breath hydrogen cyanide as a marker of early Pseudomonas aeruginosa infection in children with cystic fibrosis
by: Gilchrist, Francis J., et al.
Published: (2015)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
by: Floto, R. Andres, et al.
Published: (2016)

Perception of first respiratory infection with Pseudomonas aeruginosa by people with cystic fibrosis and those close to them: an online qualitative study
by: Palser, Sally C., et al.
Published: (2016)

Lectin-mediated biofilm maturation, quorum sensing and Pseudomonas aeruginosa infections in cystic fibrosis
by: Crusz, S.A.
Published: (2009)

Inhibition of co-colonizing cystic fibrosis-associated pathogens by Pseudomonas aeruginosa and Burkholderia multivorans
by: Costello, A., et al.
Published: (2014)

Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
by: Hutchinson, John P., et al.
Published: (2015)

Multiple-breath washout as a lung function test in cystic fibrosis: A cystic fibrosis foundation workshop report
by: Subbarao, P., et al.
Published: (2015)

Recombination is a key driver of genomic and phenotypic diversity in a Pseudomonas aeruginosa population during cystic fibrosis infection
by: Darch, Sophie E., et al.
Published: (2015)

Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis
by: Hurley, M., et al.
Published: (2015)

sTREM-1 is elevated in cystic fibrosis and correlates with proteases
by: Forrester, D.L., et al.
Published: (2017)

Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis
by: Smyth, Alan R.
Published: (2015)

Measures of body habitus are associated with lung function in adults with cystic fibrosis: a population-based study
by: Forrester, Doug L., et al.
Published: (2013)

Increasing global mortality from idiopathic pulmonary fibrosis in the twenty-first century
by: Hutchinson, John P., et al.
Published: (2014)

HOST DEFENCE PEPTIDE AS AN INNOVATIVE NOVEL THERAPY FOR PSEUDOMONAS AERUGINOSA BIOFILM INFECTIONS IN THE CYSTIC FIBROSIS LUNG
by: Wannigama, D., et al.
Published: (2019)

Surviving and thriving in the cystic fibrosis lung: contribution of an arginine specific aminopeptidase to sustained infection by Pseudomonas aeruginosa
by: Spencer, Daniella Lucy
Published: (2019)

Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis
by: Hurley, M.N., et al.
Published: (2012)

Glutamine supplementation in cystic fibrosis: a randomized placebo-controlled trial
by: Forrester, Doug L., et al.
Published: (2015)

Cystic Fibrosis James Lind Alliance Priority Setting Partnership PROTOCOL [5 February 2016]
by: Smyth, Alan R., et al.
Published: (2016)

Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis
by: Smyth, Alan R., et al.
Published: (2014)

Cystic Fibrosis James Lind Alliance Priority Setting Partnership PROTOCOL [updated 13 July 2016]
by: Smyth, Alan R., et al.
Published: (2016)

Perceptions of Population Cystic Fibrosis Prenatal and Preconception Carrier Screening Among Individuals with Cystic Fibrosis and Their Family Members
by: Maxwell, Susannah, et al.
Published: (2011)

Prescribing practices for intravenous aminoglycosides in UK cystic fibrosis clinics: a questionnaire survey
by: Smyth, Alan R., et al.
Published: (2014)

Elucidating and Utilising the Mechanisms Used by Pseudomonas aeruginosa to Develop Resistance to Bacteriophages to Aid Therapeutic Formulation and Application in Cystic Fibrosis
by: Vaitekenas, Andrew
Published: (2023)

Can aerosolised bacteriophage preparations against Pseudomonas aeruginosa protect against endotoxin-mediated inflammation in the lungs of people with cystic fibrosis?
by: Trend, S., et al.
Published: (2016)

Cystic Fibrosis isolates of Pseudomonas aeruginosa retain iron-regulated antimicrobial activity against Staphylococcus aureus through the action of multiple alkylquinolones
by: Nguyen, Angela T., et al.
Published: (2016)

The potential of phage therapy in cystic fibrosis: Essential human-bacterial-phage interactions and delivery considerations for use in Pseudomonas aeruginosa-infected airways
by: Trend, S., et al.
Published: (2017)

European Cystic Fibrosis Society standards of care: best practice guidelines
by: Smyth, Alan R., et al.
Published: (2014)

Prevention of treatment related adverse effects in cystic fibrosis
by: Jain, Kamini
Published: (2018)